Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tibor Hlavaty

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
European Journal of Gastroenterology & Hepatology|April 12, 2014
Biosimilars in the therapy of inflammatory bowel diseasesTibor Hlavaty, Juraj Letkovsky
Current Gastroenterology Reports|November 6, 2004
Advances in medical therapy for Crohn's diseaseGeert D'Haens, Tibor Hlavaty
Journal of Crohn'S & Colitis|June 6, 2015
Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much?Tibor Hlavaty, Anna Krajcovicova, Juraj Payer
Scandinavian Journal of Gastroenterology|December 21, 2011
Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factorsTomas Koller, Jana Kollerova, Tibor Hlavaty, et al.
European Journal of Gastroenterology & Hepatology|February 11, 2014
Delayed hypersensitivity reaction after initial dose of infliximab: a case reportAnna Krajcovicova, Tibor Hlavaty, Zuzana Zelinkova, et al.
Inflammatory Bowel Diseases|January 9, 2007
Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictorsTibor Hlavaty, Marc Ferrante, Liesbet Henckaerts, et al.
World Journal of Gastroenterology|November 18, 2014
Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseasesTibor Hlavaty, Anna Krajcovicova, Tomas Koller, et al.
European Journal of Gastroenterology & Hepatology|May 24, 2011
Colorectal cancer screening in patients with ulcerative and Crohn's colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopyTibor Hlavaty, Martin Huorka, Tomas Koller, et al.
United European Gastroenterology Journal|June 12, 2014
Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: A Slovak case-control studyTibor Hlavaty, Jozef Toth, Tomas Koller, et al.
Inflammatory Bowel Diseases|March 15, 2006
Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's diseaseTibor Hlavaty, Philippe Persoons, Severine Vermeire, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Gastroenterology & Hepatology|April 12, 2014
Biosimilars in the therapy of inflammatory bowel diseasesTibor Hlavaty, Juraj Letkovsky
Current Gastroenterology Reports|November 6, 2004
Advances in medical therapy for Crohn's diseaseGeert D'Haens, Tibor Hlavaty
Journal of Crohn'S & Colitis|June 6, 2015
Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much?Tibor Hlavaty, Anna Krajcovicova, Juraj Payer
Scandinavian Journal of Gastroenterology|December 21, 2011
Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factorsTomas Koller, Jana Kollerova, Tibor Hlavaty, et al.
European Journal of Gastroenterology & Hepatology|February 11, 2014
Delayed hypersensitivity reaction after initial dose of infliximab: a case reportAnna Krajcovicova, Tibor Hlavaty, Zuzana Zelinkova, et al.
Inflammatory Bowel Diseases|January 9, 2007
Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictorsTibor Hlavaty, Marc Ferrante, Liesbet Henckaerts, et al.
World Journal of Gastroenterology|November 18, 2014
Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseasesTibor Hlavaty, Anna Krajcovicova, Tomas Koller, et al.
European Journal of Gastroenterology & Hepatology|May 24, 2011
Colorectal cancer screening in patients with ulcerative and Crohn's colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopyTibor Hlavaty, Martin Huorka, Tomas Koller, et al.
United European Gastroenterology Journal|June 12, 2014
Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: A Slovak case-control studyTibor Hlavaty, Jozef Toth, Tomas Koller, et al.
Inflammatory Bowel Diseases|March 15, 2006
Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's diseaseTibor Hlavaty, Philippe Persoons, Severine Vermeire, et al.
Pageof 3